SCHEMBL2860001

SCHEMBL2860001

Nc1ccc2c(c1)c(-c1cccc(F)c1)nn2C(c1ccccc1)(c1ccccc1)c1ccccc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA2A P29274 5/20 0.42
PTGER1 P34995 3/20 0.39
TAAR1 Q96RJ0 1/20 0.39
ADORA1 P30542 4/20 0.38
ADORA2B P29275 1/20 0.38
DPP4 P27487 1/20 0.38
ABCG2 Q9UNQ0 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
ALDH1A1 P00352 2/20 0.35
LMNA P02545 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
KDM4E B2RXH2 1/20 0.34
XBP1 P17861 1/20 0.34
MAPK1 P28482 1/20 0.34
HTT P42858 1/20 0.34
CSNK1E P49674 1/20 0.34
ACHE P22303 2/20 0.33
MAT2A P31153 1/20 0.33
CNR1 P21554 1/20 0.33
CNR2 P34972 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2467474 0.88 ALDH1A1 (0.47) ADORA2AADORA1ABCG2TDP1ALDH1A1
SCHEMBL2469222 0.88 ADORA2A (0.38) ADORA2APTGER1ADORA1ABCG2TDP1
SCHEMBL2872658 0.85 ADORA2A (0.41) ADORA2APTGER1TAAR1ADORA1ADORA2B
SCHEMBL27536115 0.83 ALDH1A1 (0.41) PTGER1ABCG2ALDH1A1LMNANPSR1
SCHEMBL2861558 0.83 PTGER1 (0.39) ADORA2APTGER1ADORA1DPP4ALDH1A1
SCHEMBL2861890 0.83 PTGER1 (0.37) ADORA2APTGER1TAAR1ADORA1DPP4
SCHEMBL2857935 0.82 ADORA2A (0.41) ADORA2APTGER1TAAR1ADORA1ADORA2B
SCHEMBL173515 0.81 PTGER1 (0.38) ADORA2APTGER1ADORA1TDP1ALDH1A1
SCHEMBL30084116 0.81 PTGER1 (0.38) ADORA2APTGER1ADORA1TDP1ALDH1A1
SCHEMBL4136387 0.81 CSNK2A2 (0.41) ADORA2APTGER1ADORA1ADORA2BABCG2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7776890-B2 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2010-08-17 US disclosed
EP-1380576-B1 1H-INDAZOLE COMPOUNDS INHIBITING JNK EISAI R&D MAN CO LTD (JP) 2009-11-25 EP disclosed
US-20090203691-A1 Novel 1H-indazole compounds OINUMA HITOSHI 2009-08-13 US disclosed
US-7541376-B2 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2009-06-02 US disclosed
US-6982274-B2 1H-indazole compound EISAI CO., LTD. (JP) 2006-01-03 US disclosed
US-20050282880-A1 Novel 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2005-12-22 US disclosed
US-20040127538-A1 Novel 1h-indazole compound EISAI R&D MANAGEMENT CO., LTD. (JP) 2004-07-01 US disclosed
EP-1380576-A1 NOVEL 1H-INDAZOLE COMPOUND Eisai Co., Ltd. (JP) 2004-01-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090203691-A1 Novel 1H-indazole compounds MAPK1, MAPK3, MAPK13 ADORA2A 3048/4885PTGER1 3143/4885TAAR1 802/4885
US-20040127538-A1 Novel 1h-indazole compound MAPK1, MAPK14, MAPK3 ADORA2A 4348/4885PTGER1 4240/4885TAAR1 1627/4885
US-20050282880-A1 Novel 1H-indazole compounds MAPK1, MAPK3, MAPK13 ADORA2A 3048/4885PTGER1 3143/4885TAAR1 802/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.